Epperly Corinne 4

What Happened

• Corinne Epperly, a director of IN8BIO, was granted an award of 22,000 derivative shares (transaction code A) on May 9, 2026. The grant shows $0 paid per share (no cash exchanged). This is a compensation award rather than an open‑market purchase or sale.

Key Details

• Transaction date: May 9, 2026; Filing date: May 12, 2026 (three days after the reported transaction date).
• Price: $0.00 per share (derivative award).
• Shares involved: 22,000 shares granted.
• Shares owned after transaction: Not specified in the filing.
• Vesting footnote: 1/12th of the shares vest in equal monthly installments beginning June 9, 2026; the award will fully vest on the date of the company’s next annual meeting of stockholders if the reporting person continues to provide service.
• No 10b5-1 plan, tax‑withholding, or sale reported in this filing.

Context

• This is a compensation grant to a director (not an open‑market buy or sell). Such awards are common for board compensation and do not indicate an immediate purchase or sale of stock. The award vests over time and could convert into reportable owned shares as vesting occurs.